Innovation
Access
Available Technologies
Contact Us
Innovation
Access
Available Technologies
Contact Us
Request Information
Download PDF
Permalink
Print
This technology is currently not available for licensing
Tech ID: 27056
Share This
Additional Technologies by these Inventors
Conjugates That Combine HDAC Inhibitors and Retinoids into Disease Preventatives/Treatments
MiR-22 as a Potential Treatment Target for Steatohepatitis and Type 2 Diabetes Mellitus